La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Parkinson's disease, smoking, and family history

Identifieur interne : 000141 ( PascalFrancis/Curation ); précédent : 000140; suivant : 000142

Parkinson's disease, smoking, and family history

Auteurs : Alexis Elbaz [France] ; José Maria Manubens-Bertran [Espagne] ; Marzia Baldereschi [Italie] ; Monique M. B. Breteler [Pays-Bas] ; Francesco Grigoletto [Italie] ; Secundino Lopez-Pousa [Espagne] ; Jean-Francois Dartigues [France] ; Annick Alperovitch [France] ; Walter A. Rocca [États-Unis] ; Christophe Tzourio [France]

Source :

RBID : Pascal:00-0531976

Descripteurs français

English descriptors

Abstract

There is growing evidence that both genetic and environmental factors play a role in the etiology of Parkinson's disease (PD). The hypothesis of an interaction between genetic and environmental risk factors has been little explored, and never using a population-based case-control study design. Our objective was to investigate the possible interaction between smoking and family history in the etiology of PD, as part of a collaborative population-based case-control study. We included 149 nondemented PD patients ascertained in three European prevalence surveys using a two-phase design. Each patient was matched by age (±2 years), gender, and center to three controls drawn from the same populations (n=375). Presence of PD among first-degree relatives and smoking history were assessed through an interview for 127 cases and 306 controls. In the overall sample we found suggestive evidence that family history and eversmoking interact in determining the risk of PD (P=0.09), with individuals exposed to both risk factors having the highest risk (OR=10.0; 95 % CI=2.0-49.6). Analyses were repeated after stratification into two age-groups (cutoff: 75 years). In older patients, the joint exposure to both risk factors was associated with a significant increase in the risk of PD (OR=17.6; 95 % CI=1.9-160.5). Among younger subjects, the OR for joint exposure was not significant. In conclusion, our findings suggest that smoking and family history interact synergistically on a multiplicative scale in determining the risk of PD in individuals older than 75 years.
pA  
A01 01  1    @0 0340-5354
A02 01      @0 JNRYA9
A03   1    @0 J. neurol.
A05       @2 247
A06       @2 10
A08 01  1  ENG  @1 Parkinson's disease, smoking, and family history
A11 01  1    @1 ELBAZ (Alexis)
A11 02  1    @1 MANUBENS-BERTRAN (José Maria)
A11 03  1    @1 BALDERESCHI (Marzia)
A11 04  1    @1 BRETELER (Monique M. B.)
A11 05  1    @1 GRIGOLETTO (Francesco)
A11 06  1    @1 LOPEZ-POUSA (Secundino)
A11 07  1    @1 DARTIGUES (Jean-Francois)
A11 08  1    @1 ALPEROVITCH (Annick)
A11 09  1    @1 ROCCA (Walter A.)
A11 10  1    @1 TZOURIO (Christophe)
A14 01      @1 INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière @2 75651 Paris @3 FRA @Z 1 aut. @Z 8 aut. @Z 10 aut.
A14 02      @1 Department of Neurology, University of Navarra @2 Pamplona @3 ESP @Z 2 aut.
A14 03      @1 Targeted Project on Aging, National Research Council @2 Florence @3 ITA @Z 3 aut.
A14 04      @1 Department of Epidemiology and Biostatistics, Erasmus University Medical School @2 Rotterdam @3 NLD @Z 4 aut.
A14 05      @1 Institute of Hygiene, University of Padua @2 Padua @3 ITA @Z 5 aut.
A14 06      @1 Department of Neurology, University Hospital Sta. Caterina @2 Girona @3 ESP @Z 6 aut.
A14 07      @1 Department of Neurology, Pellegrin Hospital, University of Bordeaux II @2 Bordeaux @3 FRA @Z 7 aut.
A14 08      @1 Departments of Health Sciences Research and Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW @2 Rochester, 55905 MN @3 USA @Z 9 aut.
A17 01  1    @1 EUROPARKINSON Study Group @3 EUR
A20       @1 793-798
A21       @1 2000
A23 01      @0 ENG
A43 01      @1 INIST @2 4826 @5 354000092964510080
A44       @0 0000 @1 © 2000 INIST-CNRS. All rights reserved.
A45       @0 29 ref.
A47 01  1    @0 00-0531976
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of neurology
A66 01      @0 DEU
C01 01    ENG  @0 There is growing evidence that both genetic and environmental factors play a role in the etiology of Parkinson's disease (PD). The hypothesis of an interaction between genetic and environmental risk factors has been little explored, and never using a population-based case-control study design. Our objective was to investigate the possible interaction between smoking and family history in the etiology of PD, as part of a collaborative population-based case-control study. We included 149 nondemented PD patients ascertained in three European prevalence surveys using a two-phase design. Each patient was matched by age (±2 years), gender, and center to three controls drawn from the same populations (n=375). Presence of PD among first-degree relatives and smoking history were assessed through an interview for 127 cases and 306 controls. In the overall sample we found suggestive evidence that family history and eversmoking interact in determining the risk of PD (P=0.09), with individuals exposed to both risk factors having the highest risk (OR=10.0; 95 % CI=2.0-49.6). Analyses were repeated after stratification into two age-groups (cutoff: 75 years). In older patients, the joint exposure to both risk factors was associated with a significant increase in the risk of PD (OR=17.6; 95 % CI=1.9-160.5). Among younger subjects, the OR for joint exposure was not significant. In conclusion, our findings suggest that smoking and family history interact synergistically on a multiplicative scale in determining the risk of PD in individuals older than 75 years.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Parkinson maladie @5 01
C03 01  X  ENG  @0 Parkinson disease @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @5 01
C03 02  X  FRE  @0 Tabagisme @5 04
C03 02  X  ENG  @0 Tobacco smoking @5 04
C03 02  X  SPA  @0 Tabaquismo @5 04
C03 03  X  FRE  @0 Histoire familiale @5 07
C03 03  X  ENG  @0 Family story @5 07
C03 03  X  SPA  @0 Historia familiar @5 07
C03 04  X  FRE  @0 Europe @2 NG @5 16
C03 04  X  ENG  @0 Europe @2 NG @5 16
C03 04  X  SPA  @0 Europa @2 NG @5 16
C03 05  X  FRE  @0 Epidémiologie @5 17
C03 05  X  ENG  @0 Epidemiology @5 17
C03 05  X  SPA  @0 Epidemiología @5 17
C03 06  X  FRE  @0 Facteur risque @5 18
C03 06  X  ENG  @0 Risk factor @5 18
C03 06  X  SPA  @0 Factor riesgo @5 18
C03 07  X  FRE  @0 Homme @5 20
C03 07  X  ENG  @0 Human @5 20
C03 07  X  SPA  @0 Hombre @5 20
C03 08  X  FRE  @0 Etude cas témoin @5 23
C03 08  X  ENG  @0 Case control study @5 23
C03 08  X  SPA  @0 Estudio caso control @5 23
C07 01  X  FRE  @0 Système nerveux pathologie @5 37
C07 01  X  ENG  @0 Nervous system diseases @5 37
C07 01  X  SPA  @0 Sistema nervioso patología @5 37
C07 02  X  FRE  @0 Système nerveux central pathologie @5 38
C07 02  X  ENG  @0 Central nervous system disease @5 38
C07 02  X  SPA  @0 Sistema nervosio central patología @5 38
C07 03  X  FRE  @0 Encéphale pathologie @5 39
C07 03  X  ENG  @0 Cerebral disorder @5 39
C07 03  X  SPA  @0 Encéfalo patología @5 39
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 40
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 05  X  FRE  @0 Maladie dégénérative @5 41
C07 05  X  ENG  @0 Degenerative disease @5 41
C07 05  X  SPA  @0 Enfermedad degenerativa @5 41
N21       @1 353

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:00-0531976

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Parkinson's disease, smoking, and family history</title>
<author>
<name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Manubens Bertran, Jose Maria" sort="Manubens Bertran, Jose Maria" uniqKey="Manubens Bertran J" first="José Maria" last="Manubens-Bertran">José Maria Manubens-Bertran</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, University of Navarra</s1>
<s2>Pamplona</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Baldereschi, Marzia" sort="Baldereschi, Marzia" uniqKey="Baldereschi M" first="Marzia" last="Baldereschi">Marzia Baldereschi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Targeted Project on Aging, National Research Council</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Breteler, Monique M B" sort="Breteler, Monique M B" uniqKey="Breteler M" first="Monique M. B." last="Breteler">Monique M. B. Breteler</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Epidemiology and Biostatistics, Erasmus University Medical School</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Grigoletto, Francesco" sort="Grigoletto, Francesco" uniqKey="Grigoletto F" first="Francesco" last="Grigoletto">Francesco Grigoletto</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Institute of Hygiene, University of Padua</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Lopez Pousa, Secundino" sort="Lopez Pousa, Secundino" uniqKey="Lopez Pousa S" first="Secundino" last="Lopez-Pousa">Secundino Lopez-Pousa</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Department of Neurology, University Hospital Sta. Caterina</s1>
<s2>Girona</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Dartigues, Jean Francois" sort="Dartigues, Jean Francois" uniqKey="Dartigues J" first="Jean-Francois" last="Dartigues">Jean-Francois Dartigues</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Neurology, Pellegrin Hospital, University of Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alperovitch">Annick Alperovitch</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Departments of Health Sciences Research and Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW</s1>
<s2>Rochester, 55905 MN</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">00-0531976</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0531976 INIST</idno>
<idno type="RBID">Pascal:00-0531976</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001297</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000141</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Parkinson's disease, smoking, and family history</title>
<author>
<name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Manubens Bertran, Jose Maria" sort="Manubens Bertran, Jose Maria" uniqKey="Manubens Bertran J" first="José Maria" last="Manubens-Bertran">José Maria Manubens-Bertran</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, University of Navarra</s1>
<s2>Pamplona</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Baldereschi, Marzia" sort="Baldereschi, Marzia" uniqKey="Baldereschi M" first="Marzia" last="Baldereschi">Marzia Baldereschi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Targeted Project on Aging, National Research Council</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Breteler, Monique M B" sort="Breteler, Monique M B" uniqKey="Breteler M" first="Monique M. B." last="Breteler">Monique M. B. Breteler</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Epidemiology and Biostatistics, Erasmus University Medical School</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Grigoletto, Francesco" sort="Grigoletto, Francesco" uniqKey="Grigoletto F" first="Francesco" last="Grigoletto">Francesco Grigoletto</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Institute of Hygiene, University of Padua</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Lopez Pousa, Secundino" sort="Lopez Pousa, Secundino" uniqKey="Lopez Pousa S" first="Secundino" last="Lopez-Pousa">Secundino Lopez-Pousa</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Department of Neurology, University Hospital Sta. Caterina</s1>
<s2>Girona</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Dartigues, Jean Francois" sort="Dartigues, Jean Francois" uniqKey="Dartigues J" first="Jean-Francois" last="Dartigues">Jean-Francois Dartigues</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Neurology, Pellegrin Hospital, University of Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alperovitch">Annick Alperovitch</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Departments of Health Sciences Research and Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW</s1>
<s2>Rochester, 55905 MN</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of neurology</title>
<title level="j" type="abbreviated">J. neurol.</title>
<idno type="ISSN">0340-5354</idno>
<imprint>
<date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of neurology</title>
<title level="j" type="abbreviated">J. neurol.</title>
<idno type="ISSN">0340-5354</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Case control study</term>
<term>Epidemiology</term>
<term>Europe</term>
<term>Family story</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Risk factor</term>
<term>Tobacco smoking</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Tabagisme</term>
<term>Histoire familiale</term>
<term>Europe</term>
<term>Epidémiologie</term>
<term>Facteur risque</term>
<term>Homme</term>
<term>Etude cas témoin</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Tabagisme</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is growing evidence that both genetic and environmental factors play a role in the etiology of Parkinson's disease (PD). The hypothesis of an interaction between genetic and environmental risk factors has been little explored, and never using a population-based case-control study design. Our objective was to investigate the possible interaction between smoking and family history in the etiology of PD, as part of a collaborative population-based case-control study. We included 149 nondemented PD patients ascertained in three European prevalence surveys using a two-phase design. Each patient was matched by age (±2 years), gender, and center to three controls drawn from the same populations (n=375). Presence of PD among first-degree relatives and smoking history were assessed through an interview for 127 cases and 306 controls. In the overall sample we found suggestive evidence that family history and eversmoking interact in determining the risk of PD (P=0.09), with individuals exposed to both risk factors having the highest risk (OR=10.0; 95 % CI=2.0-49.6). Analyses were repeated after stratification into two age-groups (cutoff: 75 years). In older patients, the joint exposure to both risk factors was associated with a significant increase in the risk of PD (OR=17.6; 95 % CI=1.9-160.5). Among younger subjects, the OR for joint exposure was not significant. In conclusion, our findings suggest that smoking and family history interact synergistically on a multiplicative scale in determining the risk of PD in individuals older than 75 years.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0340-5354</s0>
</fA01>
<fA02 i1="01">
<s0>JNRYA9</s0>
</fA02>
<fA03 i2="1">
<s0>J. neurol.</s0>
</fA03>
<fA05>
<s2>247</s2>
</fA05>
<fA06>
<s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Parkinson's disease, smoking, and family history</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ELBAZ (Alexis)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MANUBENS-BERTRAN (José Maria)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>BALDERESCHI (Marzia)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>BRETELER (Monique M. B.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>GRIGOLETTO (Francesco)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>LOPEZ-POUSA (Secundino)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>DARTIGUES (Jean-Francois)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>ALPEROVITCH (Annick)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>ROCCA (Walter A.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>TZOURIO (Christophe)</s1>
</fA11>
<fA14 i1="01">
<s1>INSERM U 360, Recherches Epidémiologiques en Neurologie et Psychopathologie, Hôpital de la Salpêtrière</s1>
<s2>75651 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Neurology, University of Navarra</s1>
<s2>Pamplona</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Targeted Project on Aging, National Research Council</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Epidemiology and Biostatistics, Erasmus University Medical School</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Institute of Hygiene, University of Padua</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Neurology, University Hospital Sta. Caterina</s1>
<s2>Girona</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Department of Neurology, Pellegrin Hospital, University of Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Departments of Health Sciences Research and Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW</s1>
<s2>Rochester, 55905 MN</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1">
<s1>EUROPARKINSON Study Group</s1>
<s3>EUR</s3>
</fA17>
<fA20>
<s1>793-798</s1>
</fA20>
<fA21>
<s1>2000</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>4826</s2>
<s5>354000092964510080</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>29 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>00-0531976</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of neurology</s0>
</fA64>
<fA66 i1="01">
<s0>DEU</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>There is growing evidence that both genetic and environmental factors play a role in the etiology of Parkinson's disease (PD). The hypothesis of an interaction between genetic and environmental risk factors has been little explored, and never using a population-based case-control study design. Our objective was to investigate the possible interaction between smoking and family history in the etiology of PD, as part of a collaborative population-based case-control study. We included 149 nondemented PD patients ascertained in three European prevalence surveys using a two-phase design. Each patient was matched by age (±2 years), gender, and center to three controls drawn from the same populations (n=375). Presence of PD among first-degree relatives and smoking history were assessed through an interview for 127 cases and 306 controls. In the overall sample we found suggestive evidence that family history and eversmoking interact in determining the risk of PD (P=0.09), with individuals exposed to both risk factors having the highest risk (OR=10.0; 95 % CI=2.0-49.6). Analyses were repeated after stratification into two age-groups (cutoff: 75 years). In older patients, the joint exposure to both risk factors was associated with a significant increase in the risk of PD (OR=17.6; 95 % CI=1.9-160.5). Among younger subjects, the OR for joint exposure was not significant. In conclusion, our findings suggest that smoking and family history interact synergistically on a multiplicative scale in determining the risk of PD in individuals older than 75 years.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Tabagisme</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Tobacco smoking</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Tabaquismo</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Histoire familiale</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Family story</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Historia familiar</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Europe</s0>
<s2>NG</s2>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Europe</s0>
<s2>NG</s2>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Europa</s0>
<s2>NG</s2>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Epidémiologie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Epidemiology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Epidemiología</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Facteur risque</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Risk factor</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Factor riesgo</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Etude cas témoin</s0>
<s5>23</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Case control study</s0>
<s5>23</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Estudio caso control</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>353</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000141 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000141 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0531976
   |texte=   Parkinson's disease, smoking, and family history
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024